Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Feb 19, 2014

29777_dirs_2014-02-19_42a80bfe-7944-4d65-a01f-1067fa0df2ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-02-17

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-17 Common shares without par value F 608 $38.8100 Disposed 30293 Direct
2014-02-18 Common shares without par value F 325 $38.81 Disposed 29968 Direct
2014-02-18 Common shares without par value S 489 $38.965 Disposed 29479 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 2078 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2014.